Standout Papers

Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Tr... 2013 2026 2017 2021 572
  1. Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial (2013)
    Ann‐Lii Cheng, Yoon‐Koo Kang et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 147 standout
Sub-graph 1 of 13

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2024 Standout
49 intermediate papers

Works of Deng‐Yn Lin being referenced

Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
2013 Standout
Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection
2011
and 1 more

Author Peers

Author Last Decade Papers Cites
Deng‐Yn Lin 659 274 92 281 9 936
A. Sérgio 530 237 141 166 14 756
Yasushi Shiratori 556 395 165 125 18 1.1k
Túlio Pfiffer 644 255 98 261 19 861
Chao-Jung Tsao 402 302 101 153 22 769
K. G Mamontov 678 166 147 281 7 927
ST Fan 352 160 204 80 9 791
Hsiang‐Ju Lin 632 452 111 122 21 989
Iris Martinez-Quetglas 403 149 150 138 6 970
Chao‐Wei Hsu 717 554 139 70 25 946
Yasuro Niwa 544 378 154 61 13 813

All Works

Loading papers...

Rankless by CCL
2026